Expression of p25, an Aberrant Cyclin-Dependent Kinase 5 Activator, Stimulates Basal Secretion in PC12 Cells

Barclay, 2004, Regulation of the fusion pore conductance during exocytosis by cyclin-dependent kinase 5., J. Biol. Chem., 279, 41495, 10.1074/jbc.M406670200

Choi, 2007, Ameliorating effect of Gardenia jasminoides extract on amyloid beta peptideinduced neuronal cell deficit., Mol. Cells, 24, 113, 10.1016/S1016-8478(23)10762-X

Chung, 2008, Cyclin-dependent kinase 5: a critical regulator of neurotransmitter release. In cyclin dependent kinase 5 (Cdk5), N.Y. Ip, and L.H., Tsai, ed., (New York, USA: Springer US),, 35

Chung, 1998, The C2 domains of Rabphilin3A specifically bind phosphatidylinositol 4,5-bisphosphate containing vesicles in a Ca2+-dependent manner. In vitro characteristics and possible significance., J. Biol. Chem., 273, 10240, 10.1074/jbc.273.17.10240

Chung, 1999, Comparison of the effects on secretion in chromaffin and PC12 cells of Rab3 family members and mutants. Evidence that inhibitory effects are independent of direct interaction with Rabphilin3., J. Biol. Chem., 274, 18113, 10.1074/jbc.274.25.18113

Cruz, 2003, Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles., Neuron, 40, 471, 10.1016/S0896-6273(03)00627-5

Cruz, 2006, p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo., J. Neurosci., 26, 10536, 10.1523/JNEUROSCI.3133-06.2006

Csernansky, 1996, CSF excitatory amino acids and severity of illness in Alzheimer’s disease., Neurology, 46, 1715, 10.1212/WNL.46.6.1715

Elrod, 1997, Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration., Am. J. Psychiatry, 154, 25, 10.1176/ajp.154.1.25

Fletcher, 1999, Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18., J. Biol. Chem., 274, 4027, 10.1074/jbc.274.7.4027

Fu, 2005, Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclindependent kinase 5 null mice., Proc. Natl. Acad. Sci. USA, 102, 15224, 10.1073/pnas.0507678102

Fukumoto, 2002, Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease., Arch. Neurol., 59, 1381, 10.1001/archneur.59.9.1381

Graham, 1997, Evidence against an acute inhibitory role of nSec-1 (munc-18) in late steps of regulated exocytosis in chromaffin and PC12 cells., J. Neurochem., 69, 2369, 10.1046/j.1471-4159.1997.69062369.x

Holz, 1999

Jimenez-Jimenez, 1998, Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer’s disease., J. Neural Transm., 105, 269, 10.1007/s007020050073

Kamei, 2007, Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation., J. Biol. Chem., 282, 1687, 10.1074/jbc.M610541200

Khvotchev, 2003, Divergent functions of neuronal Rab11b in Ca2+-regulated versus constitutive exocytosis., J. Neurosci., 23, 10531, 10.1523/JNEUROSCI.23-33-10531.2003

Lanari, 2006, Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer’s disease., Mech. Ageing Dev., 127, 158, 10.1016/j.mad.2005.09.016

Lee, 2004, Cdk5/p35 expression in the mouse ovary., Mol. Cells, 17, 17, 10.1016/S1016-8478(23)12999-2

Lee, 2004, Overexpression of BACE1 stimulates spontaneous basal secretion in PC12 cells., Neurosci. Lett., 421, 178, 10.1016/j.neulet.2007.01.082

Lee, 2008, Overexpression of APP stimulates basal and constitutive exocytosis in PC12 cells., Neurosci. Lett., 436, 245, 10.1016/j.neulet.2008.03.038

Lilja, 2001, Cyclin-dependent kinase 5 promotes insulin exocytosis., J. Biol. Chem., 276, 34199, 10.1074/jbc.M103776200

Lilja, 2004, Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis., J. Biol. Chem., 279, 29534, 10.1074/jbc.M312711200

Matsuuchi, 1991, Constitutive and basal secretion from the endocrine cell line, AtT-20., J. Cell Biol., 112, 843, 10.1083/jcb.112.5.843

Palmada, 1998, Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain., Front. Biosci., 3, d701, 10.2741/A314

Patrick, 1998, p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway., J. Biol. Chem., 273, 24057, 10.1074/jbc.273.37.24057

Patrick, 1999, Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration., Nature, 402, 615, 10.1038/45159

Pomara, 1992, Glutamate and other CSF amino acids in Alzheimer’s disease., Am. J. Psychiatry, 149, 251, 10.1176/ajp.149.2.251

Rosales, 2006, Extraneuronal roles of cyclindependent kinase 5., Bioessays, 28, 1023, 10.1002/bies.20473

Rosales, 2004, GTPdependent secretion from neutrophils is regulated by Cdk5., J. Biol. Chem., 279, 53932, 10.1074/jbc.M408467200

Saito, 2003, Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation., J. Neurosci., 23, 1189, 10.1523/JNEUROSCI.23-04-01189.2003

Selkoe, 2002, Alzheimer’s disease is a synaptic failure., Science, 298, 789, 10.1126/science.1074069

Smith, 1985, Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia., J. Neurol. Neurosurg. Psychiatry, 48, 469, 10.1136/jnnp.48.5.469

Sugita, 1999, Synaptogyrins regulate Ca2+-dependent exocytosis in PC12 cells., J. Biol. Chem., 274, 18893, 10.1074/jbc.274.27.18893

Swatton, 2004, Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain., Eur. J. Neurosci., 19, 2711, 10.1111/j.0953-816X.2004.03365.x

Tandon, 2003, Brain levels of CDK5 activator p25 are not increased in Alzheimer’s or other neurodegenerative diseases with neurofibrillary tangles., J. Neurochem., 86, 572, 10.1046/j.1471-4159.2003.01865.x

Tomizawa, 2002, Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Qtype voltage-dependent calcium channel activity., J. Neurosci., 22, 2590, 10.1523/JNEUROSCI.22-07-02590.2002

Tseng, 2002, A survey of Cdk5 activator p35 and p25 levels in Alzheimer’s disease brains., Febs Lett., 523, 58, 10.1016/S0014-5793(02)02934-4

van den Pol, 1998, Selective neuronal expression of green fluorescent protein with cytomegalovirus promoter reveals entire neuronal arbor in transgenic mice., J. Neurosci., 18, 10640, 10.1523/JNEUROSCI.18-24-10640.1998

Varro, 1996, Discrimination between constitutive secretion and basal secretion from the regulated secretory pathway in GH3 cells., Biochim. Biophys. Acta, 1313, 101, 10.1016/0167-4889(96)00056-0

Wen, 2008, Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing., Neuron, 57, 680, 10.1016/j.neuron.2008.02.024

Xin, 2004, Cdk5 and Trio modulate endocrine cell exocytosis., J. Cell Sci., 117, 4739, 10.1242/jcs.01333

Yang, 2003, Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease., Nat. Med., 9, 3, 10.1038/nm0103-3